| Primary |
| Hiv Infection |
75.2% |
| Product Used For Unknown Indication |
4.8% |
| Mycobacterium Avium Complex Infection |
2.6% |
| Prophylaxis |
2.2% |
| Prophylaxis Against Hiv Infection |
1.9% |
| Hypophosphataemia |
1.5% |
| Hypothyroidism |
1.5% |
| Antiretroviral Therapy |
1.1% |
| Maternal Exposure During Pregnancy |
1.1% |
| Nausea |
1.1% |
| Supplementation Therapy |
1.1% |
| Asthma |
0.7% |
| Depression |
0.7% |
| Macular Oedema |
0.7% |
| Oedema Peripheral |
0.7% |
| Opportunistic Infection |
0.7% |
| Opportunistic Infection Prophylaxis |
0.7% |
| Pruritus |
0.7% |
| Abdominal Discomfort |
0.4% |
| Abdominal Pain Upper |
0.4% |
|
| Abortion Spontaneous |
22.7% |
| Foetal Growth Restriction |
6.8% |
| Hand Fracture |
6.8% |
| Respiratory Distress |
6.8% |
| Thrombocytopenia |
6.8% |
| Arrhythmia |
4.5% |
| Bone Deformity |
4.5% |
| Calculus Ureteric |
4.5% |
| Overdose |
4.5% |
| Pregnancy |
4.5% |
| Skin Infection |
4.5% |
| Ultrasound Antenatal Screen Abnormal |
4.5% |
| Adrenal Suppression |
2.3% |
| Alanine Aminotransferase Increased |
2.3% |
| Altered State Of Consciousness |
2.3% |
| Ankyloglossia Congenital |
2.3% |
| Arterial Stenosis |
2.3% |
| Blood Creatinine Increased |
2.3% |
| Blood Phosphorus Decreased |
2.3% |
| Blood Sodium Decreased |
2.3% |
|
| Secondary |
| Hiv Infection |
58.2% |
| Product Used For Unknown Indication |
9.3% |
| Prophylaxis Against Hiv Infection |
9.3% |
| Drug Exposure During Pregnancy |
4.5% |
| Drug Use For Unknown Indication |
4.3% |
| Antiretroviral Therapy |
2.8% |
| Hypertension |
1.6% |
| Neuropathy Peripheral |
1.5% |
| Disseminated Tuberculosis |
1.2% |
| Alcohol Abuse |
1.0% |
| Insomnia |
0.9% |
| Antifungal Prophylaxis |
0.8% |
| Neurosyphilis |
0.8% |
| Toxoplasmosis |
0.8% |
| Acquired Immunodeficiency Syndrome |
0.6% |
| Gestational Diabetes |
0.6% |
| Affect Lability |
0.4% |
| Antiviral Treatment |
0.4% |
| Cerebral Toxoplasmosis |
0.4% |
| Cytomegalovirus Chorioretinitis |
0.4% |
|
| Ventricular Hypertrophy |
12.5% |
| Thrombocytopenia |
9.6% |
| Umbilical Cord Abnormality |
9.6% |
| Death |
5.8% |
| Musculoskeletal Pain |
5.8% |
| Lactic Acidosis |
4.8% |
| Premature Labour |
4.8% |
| Renal Impairment |
4.8% |
| Haematoma |
3.8% |
| Meningitis Pneumococcal |
3.8% |
| Oesophageal Perforation |
3.8% |
| Ophthalmia Neonatorum |
3.8% |
| Pancreatitis Acute |
3.8% |
| Rash Generalised |
3.8% |
| Stress |
3.8% |
| Trisomy 21 |
3.8% |
| Abortion Spontaneous |
2.9% |
| Completed Suicide |
2.9% |
| Drug Exposure During Pregnancy |
2.9% |
| Drug Interaction |
2.9% |
|
| Concomitant |
| Hiv Infection |
69.3% |
| Prophylaxis |
3.5% |
| Febrile Bone Marrow Aplasia |
2.7% |
| Interstitial Lung Disease |
2.7% |
| Product Used For Unknown Indication |
2.7% |
| Drug Exposure During Pregnancy |
2.1% |
| Hypertension |
2.1% |
| Depression |
1.7% |
| Drug Use For Unknown Indication |
1.4% |
| Epstein-barr Virus Associated Lymphoproliferative Disorder |
1.4% |
| Antifungal Prophylaxis |
1.2% |
| Epilepsy |
1.2% |
| Non-hodgkin's Lymphoma |
1.2% |
| Acquired Immunodeficiency Syndrome |
1.1% |
| Burkitt's Lymphoma |
1.1% |
| Anaemia |
0.9% |
| Convulsion Prophylaxis |
0.9% |
| Cytomegalovirus Viraemia |
0.9% |
| Dyslipidaemia |
0.9% |
| Hepatic Cirrhosis |
0.9% |
|
| Cytolytic Hepatitis |
14.3% |
| Drug Exposure During Pregnancy |
7.7% |
| Oesophageal Candidiasis |
7.7% |
| Exomphalos |
6.6% |
| Renal Tubular Necrosis |
6.6% |
| Transaminases Increased |
6.6% |
| Burkitt's Lymphoma |
5.5% |
| Cerebrovascular Accident |
4.4% |
| Myalgia |
4.4% |
| Pancreatitis Acute |
4.4% |
| Premature Baby |
4.4% |
| Syphilis |
4.4% |
| Drug Interaction |
3.3% |
| Hepatic Cirrhosis |
3.3% |
| Pneumonia |
3.3% |
| Pseudomembranous Colitis |
3.3% |
| Weight Decreased |
3.3% |
| Blood Creatinine Increased |
2.2% |
| Bone Pain |
2.2% |
| Drug Rash With Eosinophilia And Systemic Symptoms |
2.2% |
|
| Interacting |
| Hiv Infection |
47.1% |
| Infection |
47.1% |
| Drug Use For Unknown Indication |
5.9% |
|
| Renal Failure Chronic |
100.0% |
|
